Apabetalone prevents human SARS-CoV-2 infection of human lung epithelial cells at comparable levels to the antivirals remdesivir – a currently approved treatment for COVID-19 by the US Food and Drug Administration - and camostat mesylate. (Resverlogix, March 15, 2021)
https://www.forbes.com/sites/jvchamary/2021/01/31/remdesivir-covid-coronavirus/
Jan 31, 2021,06:59pm EST|
The Strange Story Of Remdesivir, A Covid Drug That Doesn’t Work
